DCM
EW icon

Dupont Capital Management’s Edwards Lifesciences EW Stock Holding History

Dupont Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,763
Closed -$206K – 900
2022
Q4 		$206K Buy
2,763
+244
+10% +$18.8K 0.01% 781
2022
Q3 		$208K Sell
2,519
-802
-24% -$77.2K 0.01% 862
2022
Q2 		$316K Buy
3,321
+401
+14% +$41.5K 0.01% 846
2022
Q1 		$344K Sell
2,920
-363
-11% -$40.7K 0.01% 885
2021
Q4 		$425K Sell
3,283
-9,288
-74% -$1.08M 0.02% 868
2021
Q3 		$1.42M Buy
+12,571
New +$1.43M 0.04% 427
2020
Q4 		– Sell
-24,513
Closed -$1.96M – 1336
2020
Q3 		$1.96M Buy
24,513
+1,007
+4% +$78.6K 0.04% 319
2020
Q2 		$1.63M Sell
23,506
-23,000
-49% -$1.63M 0.04% 365
2020
Q1 		$2.92M Buy
46,506
+14,811
+47% +$1.07M 0.07% 205
2019
Q4 		$2.46M Buy
31,695
+21,795
+220% +$1.7M 0.06% 300
2019
Q3 		$726K Hold
9,900
– – 0.02% 624
2019
Q2 		$610K Hold
9,900
– – 0.01% 693
2019
Q1 		$631K Sell
9,900
-36
-0.4% -$2.05K 0.01% 687
2018
Q4 		$507K Sell
9,936
-57,510
-85% -$2.91M 0.01% 721
2018
Q3 		$3.91M Sell
67,446
-8,322
-11% -$407K 0.09% 223
2018
Q2 		$3.68M Buy
75,768
+7,659
+11% +$357K 0.09% 210
2018
Q1 		$3.17M Buy
+68,109
New +$2.96M 0.08% 251
2017
Q4 		– Sell
-3,897
Closed -$142K – 951
2017
Q3 		$142K Buy
+3,897
New +$149K ﹤0.01% 833
2015
Q3 		– Sell
-105,864
Closed -$2.51M – 608
2015
Q2 		$2.51M Sell
105,864
-115,728
-52% -$2.61M 0.05% 307
2015
Q1 		$5.26M Buy
221,592
+25,968
+13% +$583K 0.1% 191
2014
Q4 		$4.15M Sell
195,624
-181,902
-48% -$3.65M 0.08% 217
2014
Q3 		$6.43M Buy
+377,526
New +$5.96M 0.11% 143

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Dupont Capital Management's EW Position: Q1 2023 in Review

Dupont Capital Management sold out of Edwards Lifesciences (EW) in Q1 2023, closing a stake of 2,763 shares — an estimated $206K sold.

Dupont Capital Management first reported a position in EW in Q3 2014 and held it in 22 quarters. The position peaked at $6.43M in Q3 2014. 1,246 funds tracked by Wall St. Rank hold EW as of Q1 2023.

  • Dupont Capital Management reported no remaining Edwards Lifesciences position as of Q1 2023 after selling out during the quarter.
  • Dupont Capital Management sold 2,763 Edwards Lifesciences shares in Q1 2023, an estimated $206K.
  • Dupont Capital Management first reported a position in Edwards Lifesciences in Q3 2014 and held it in 22 quarters.
  • Dupont Capital Management's Edwards Lifesciences position peaked at $6.43M in Q3 2014.
  • 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.